[{"internal_id": 50035024, "Award ID": "TC251431360A20", "Award Amount": 2594709.17, "Award Type": null, "Base Obligation Date": "2013-09-24", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE COMMUNITY COLLEGE AND CAREER TRAINING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "0d785b51-3193-f840-b0e7-a4d582c26d7f-C", "generated_internal_id": "ASST_NON_TC251431360A20_1630"}, {"internal_id": 50034871, "Award ID": "TC238511260A42", "Award Amount": 2178852.25, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2012-09-28", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE COMMUNITY COLLEGE AND CAREER TRAINING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e29c214c-28cf-7a93-6b85-8e5cad4727c4-C", "generated_internal_id": "ASST_NON_TC238511260A42_1630"}, {"internal_id": 50034859, "Award ID": "TC238391260A9", "Award Amount": 2497309.1, "Award Type": null, "Base Obligation Date": "2012-09-27", "CFDA Number": "17.282", "Description": "TRADE ADJUSTMENT ASSISTANCE COMMUNITY COLLEGE AND CAREER TRAINING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "897847d7-530e-ddb2-faa0-0c44a05cffd9-C", "generated_internal_id": "ASST_NON_TC238391260A9_1630"}, {"internal_id": 50034856, "Award ID": "TC238361260A2", "Award Amount": 1991696.28, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2012-09-27", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE COMMUNITY COLLEGE AND CAREER TRAINING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AK", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "569c2448-3ce6-f2a2-0e2b-5d95a748f551-C", "generated_internal_id": "ASST_NON_TC238361260A2_1630"}, {"internal_id": 50034855, "Award ID": "TC238271260A25", "Award Amount": 2969371.25, "Award Type": null, "Base Obligation Date": "2012-09-27", "CFDA Number": "17.282", "Description": "TRADE ADJUSTMENT ASSISTANCE COMMUNITY COLLEGE AND CAREER TRAINING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "a8924106-e0a0-f0fa-4438-c3bc9315451e-C", "generated_internal_id": "ASST_NON_TC238271260A25_1630"}, {"internal_id": 50034852, "Award ID": "TC237941260A20", "Award Amount": 14450999.82, "Award Type": null, "Base Obligation Date": "2012-09-26", "CFDA Number": "17.282", "Description": "TRADE ADJUSTMENT ASSISTANCE COMMUNITY COLLEGE AND CAREER TRAINING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "6167ced6-a3d4-6963-a611-53618df4e8cb-C", "generated_internal_id": "ASST_NON_TC237941260A20_1630"}, {"internal_id": 50034847, "Award ID": "TC237891260A50", "Award Amount": 3348244.11, "Award Type": null, "Base Obligation Date": "2012-09-26", "CFDA Number": "17.282", "Description": "TRADE ADJUSTMENT ASSISTANCE COMMUNITY COLLEGE AND CAREER TRAINING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5e59f9d4-1ccc-0554-44e0-2a86d0d53ecb-C", "generated_internal_id": "ASST_NON_TC237891260A50_1630"}, {"internal_id": 50034834, "Award ID": "TC237761260A51", "Award Amount": 11094650.41, "Award Type": null, "Base Obligation Date": "2012-09-27", "CFDA Number": "17.282", "Description": "TRADE ADJUSTMENT ASSISTANCE COMMUNITY COLLEGE AND CAREER TRAINING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "552c73c4-765a-ead3-88dd-48684c4f689c-C", "generated_internal_id": "ASST_NON_TC237761260A51_1630"}, {"internal_id": 50034830, "Award ID": "TC237721260A36", "Award Amount": 14295914.14, "Award Type": null, "Base Obligation Date": "2012-09-26", "CFDA Number": "17.282", "Description": "TRADE ADJUSTMENT ASSISTANCE COMMUNITY COLLEGE AND CAREER TRAINING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "a0e5d1eb-8d8d-9ad6-9d70-fb6e892100df-C", "generated_internal_id": "ASST_NON_TC237721260A36_1630"}, {"internal_id": 50034785, "Award ID": "TC225341160A56", "Award Amount": 2128309.04, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2011-09-29", "CFDA Number": "17.282", "Description": "TRADE ADJUSTMENT ASSISTANCE COMMUNITY COLLEGE AND CAREER TRAINING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ef08e0f9-5e79-01e5-a7e9-544479d51eb1-C", "generated_internal_id": "ASST_NON_TC225341160A56_1630"}, {"internal_id": 50034778, "Award ID": "TC225171160A17", "Award Amount": 17011737.37, "Award Type": null, "Base Obligation Date": "2011-09-29", "CFDA Number": "17.282", "Description": "TRADE ADJUSTMENT ASSISTANCE COMMUNITY COLLEGE AND CAREER TRAINING", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "56d6d0e2-f0e2-7f2b-dc9a-0a0c5c675965-C", "generated_internal_id": "ASST_NON_TC225171160A17_1630"}, {"internal_id": 151476360, "Award ID": "TA389492255A44", "Award Amount": 2626000.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-08-22", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\n SUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "RI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e9f0421d-cc22-21bc-7918-abb8af4d0be3-C", "generated_internal_id": "ASST_NON_TA389492255A44_1630"}, {"internal_id": 150204850, "Award ID": "TA387122255A55", "Award Amount": 6543576.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\nSTATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\n SUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7a7c092b-646d-1d43-0318-57b1f0f6b91d-C", "generated_internal_id": "ASST_NON_TA387122255A55_1630"}, {"internal_id": 150204851, "Award ID": "TA387112255A54", "Award Amount": 4352341.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\nSTATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\n\n\nSUBRECIPIENT ACTIVITIES\n SUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WV", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "846a8e3f-aa4e-18cf-c266-755ef5d9cd3b-C", "generated_internal_id": "ASST_NON_TA387112255A54_1630"}, {"internal_id": 150204852, "Award ID": "TA387102255A53", "Award Amount": 21039561.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\n SUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d32cbf7c-8ae1-2ea4-a158-a0c25c70233f-C", "generated_internal_id": "ASST_NON_TA387102255A53_1630"}, {"internal_id": 150204847, "Award ID": "TA387092255A51", "Award Amount": 5140730.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-14", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\n SUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "cdf64453-c591-7dc4-091e-bcc8ce4b3bf8-C", "generated_internal_id": "ASST_NON_TA387092255A51_1630"}, {"internal_id": 150204848, "Award ID": "TA387082255A50", "Award Amount": 364182.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\nSTATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\n SUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "188ec089-7e55-6993-1b6c-c45633c5c525-C", "generated_internal_id": "ASST_NON_TA387082255A50_1630"}, {"internal_id": 150204849, "Award ID": "TA387072255A49", "Award Amount": 2243943.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\n SUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "UT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "884e85e0-5b57-c7bb-0320-0269c0f42caa-C", "generated_internal_id": "ASST_NON_TA387072255A49_1630"}, {"internal_id": 150204846, "Award ID": "TA387062255A48", "Award Amount": 16388707.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\n SUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TX", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3f8e6ab8-83f5-3b05-d70f-d6922a8a565e-C", "generated_internal_id": "ASST_NON_TA387062255A48_1630"}, {"internal_id": 150204853, "Award ID": "TA387052255A47", "Award Amount": 2671352.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d15d67ff-9bea-1e97-7a91-c4da003d04dd-C", "generated_internal_id": "ASST_NON_TA387052255A47_1630"}, {"internal_id": 150204854, "Award ID": "TA387042255A46", "Award Amount": 1366836.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "SD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "359d1c64-c8d3-a5e4-434d-d7d7db0491f7-C", "generated_internal_id": "ASST_NON_TA387042255A46_1630"}, {"internal_id": 150511193, "Award ID": "TA387032255A45", "Award Amount": 2480524.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-19", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "SC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7c0ab944-f413-12ab-2f1d-8c8c0b402d24-C", "generated_internal_id": "ASST_NON_TA387032255A45_1630"}, {"internal_id": 150511185, "Award ID": "TA387022255A72", "Award Amount": 111866.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-19", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8e5e253b-7d1e-bd25-2657-ed39b259a96f-C", "generated_internal_id": "ASST_NON_TA387022255A72_1630"}, {"internal_id": 150204855, "Award ID": "TA387012255A42", "Award Amount": 15269349.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "67111aba-ca04-649d-f45a-abf9aa28596f-C", "generated_internal_id": "ASST_NON_TA387012255A42_1630"}, {"internal_id": 150204856, "Award ID": "TA387002255A41", "Award Amount": 14849736.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-14", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "62e0cef4-c2a9-4de9-d873-1e95838cc67a-C", "generated_internal_id": "ASST_NON_TA387002255A41_1630"}, {"internal_id": 150204857, "Award ID": "TA386992255A40", "Award Amount": 3696236.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\nSTATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OK", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ebe1d86a-aacd-3caf-cf00-6b8e6449590a-C", "generated_internal_id": "ASST_NON_TA386992255A40_1630"}, {"internal_id": 150511186, "Award ID": "TA386982255A39", "Award Amount": 5153031.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-21", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5328a709-be88-a95a-5c48-ac49aa83adc7-C", "generated_internal_id": "ASST_NON_TA386982255A39_1630"}, {"internal_id": 150204858, "Award ID": "TA386972255A38", "Award Amount": 252354.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\nSTATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "ND", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "00a02d4a-e0eb-059f-d8e6-01ce7c006005-C", "generated_internal_id": "ASST_NON_TA386972255A38_1630"}, {"internal_id": 150204859, "Award ID": "TA386962255A37", "Award Amount": 3202735.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\nSTATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "fa2f5127-5692-2c99-8d92-577968944beb-C", "generated_internal_id": "ASST_NON_TA386962255A37_1630"}, {"internal_id": 150511196, "Award ID": "TA386952255A36", "Award Amount": 10136389.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-15", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d2a390c1-d7aa-00da-1424-3e1044c081be-C", "generated_internal_id": "ASST_NON_TA386952255A36_1630"}, {"internal_id": 150204860, "Award ID": "TA386942255A35", "Award Amount": 3145874.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NM", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "468b6b30-c12b-6ee1-ab24-76a78077e304-C", "generated_internal_id": "ASST_NON_TA386942255A35_1630"}, {"internal_id": 150511191, "Award ID": "TA386932255A34", "Award Amount": 3048907.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-20", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET\n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NJ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bbaea497-1a7f-161c-51d7-d8f3c2deccbc-C", "generated_internal_id": "ASST_NON_TA386932255A34_1630"}, {"internal_id": 150204861, "Award ID": "TA386922255A33", "Award Amount": 305263.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "544f5a0a-2ccc-8ec6-6643-9ddd180c37d2-C", "generated_internal_id": "ASST_NON_TA386922255A33_1630"}, {"internal_id": 150204862, "Award ID": "TA386912255A32", "Award Amount": 149876.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\nSTATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\n SUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NV", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c079e5d2-db3e-6b13-6c7c-407a8c93521d-C", "generated_internal_id": "ASST_NON_TA386912255A32_1630"}, {"internal_id": 150204863, "Award ID": "TA386902255A31", "Award Amount": 1177930.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\nSTATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\n SUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NE", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "53560a59-1ae6-832d-6db5-3082a56389d5-C", "generated_internal_id": "ASST_NON_TA386902255A31_1630"}, {"internal_id": 151290743, "Award ID": "TA386892255A29", "Award Amount": 4830481.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-08-19", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\nSTATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\n SUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "834c7a17-8afe-ef5c-f974-d4c78b3792cd-C", "generated_internal_id": "ASST_NON_TA386892255A29_1630"}, {"internal_id": 150511195, "Award ID": "TA386882255A28", "Award Amount": 1937034.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-19", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\nSTATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\n SUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "46c9f5fc-0124-8f41-debf-f89950f1ab76-C", "generated_internal_id": "ASST_NON_TA386882255A28_1630"}, {"internal_id": 150511190, "Award ID": "TA386872255A27", "Award Amount": 6860784.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-18", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\nSTATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "260ed1ea-1ea9-d6d1-bb92-39df0506ff29-C", "generated_internal_id": "ASST_NON_TA386872255A27_1630"}, {"internal_id": 150204865, "Award ID": "TA386862255A26", "Award Amount": 7177274.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\nSTATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8d56c54c-3c4f-9ba5-e713-5968374ddaac-C", "generated_internal_id": "ASST_NON_TA386862255A26_1630"}, {"internal_id": 150511189, "Award ID": "TA386852255A25", "Award Amount": 5793768.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-15", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\nSTATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "21d393fd-60ea-cec2-1d82-d7c447633702-C", "generated_internal_id": "ASST_NON_TA386852255A25_1630"}, {"internal_id": 150204866, "Award ID": "TA386842255A24", "Award Amount": 1292545.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "4d13a910-0420-2522-e502-49372f5c39e6-C", "generated_internal_id": "ASST_NON_TA386842255A24_1630"}, {"internal_id": 150204867, "Award ID": "TA386832255A23", "Award Amount": 243428.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "ME", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "de5f8d9c-db27-6631-fde3-7b4268a955ef-C", "generated_internal_id": "ASST_NON_TA386832255A23_1630"}, {"internal_id": 150204864, "Award ID": "TA386822255A22", "Award Amount": 1080904.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "LA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "610cdfe0-3bf4-21f8-d433-352dba7157e7-C", "generated_internal_id": "ASST_NON_TA386822255A22_1630"}, {"internal_id": 150204869, "Award ID": "TA386812255A21", "Award Amount": 3158888.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\nSTATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9594ad8f-777a-01e4-21cc-02c0438e9a13-C", "generated_internal_id": "ASST_NON_TA386812255A21_1630"}, {"internal_id": 150204870, "Award ID": "TA386802255A20", "Award Amount": 12823631.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\n\n\nSUBRECIPIENT ACTIVITIES\n SUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f956af53-7594-bbbb-8c21-e83b2595618e-C", "generated_internal_id": "ASST_NON_TA386802255A20_1630"}, {"internal_id": 150204881, "Award ID": "TA386782255A19", "Award Amount": 4662587.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "38945dff-1d01-d124-868e-296e9cd4b40e-C", "generated_internal_id": "ASST_NON_TA386782255A19_1630"}, {"internal_id": 150204871, "Award ID": "TA386772255A18", "Award Amount": 8772136.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\nSTATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "55a913e6-c7a1-e3ab-3504-a525657ec61b-C", "generated_internal_id": "ASST_NON_TA386772255A18_1630"}, {"internal_id": 150204872, "Award ID": "TA386762255A17", "Award Amount": 7864932.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\nSTATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\n SUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "49c0b4a8-3274-5dbf-bfdc-21abf88201aa-C", "generated_internal_id": "ASST_NON_TA386762255A17_1630"}, {"internal_id": 150204873, "Award ID": "TA386752255A16", "Award Amount": 751207.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\n SUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "ID", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c5fe910a-7613-4d8e-4231-e321fb6900ba-C", "generated_internal_id": "ASST_NON_TA386752255A16_1630"}, {"internal_id": 150204874, "Award ID": "TA386742255A13", "Award Amount": 3818337.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "GA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c9860cdb-a017-dfc7-57ec-e362225694da-C", "generated_internal_id": "ASST_NON_TA386742255A13_1630"}, {"internal_id": 150204875, "Award ID": "TA386732255A12", "Award Amount": 2353503.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\nSTATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "aca7fa8c-c5aa-0d3d-29a6-e143b50b9fa4-C", "generated_internal_id": "ASST_NON_TA386732255A12_1630"}, {"internal_id": 151630109, "Award ID": "TA386722255A10", "Award Amount": 229093.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-08-30", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "DE", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bbcd12b4-1518-9503-9648-0f08b880cc1b-C", "generated_internal_id": "ASST_NON_TA386722255A10_1630"}, {"internal_id": 150204876, "Award ID": "TA386712255A9", "Award Amount": 3570485.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\nSTATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "97c80fbf-3298-005f-f24e-73a8b1fd9edb-C", "generated_internal_id": "ASST_NON_TA386712255A9_1630"}, {"internal_id": 150204877, "Award ID": "TA386702255A8", "Award Amount": 3805163.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7ec1af8f-4c5f-a77c-1a5b-21acb44aa1dc-C", "generated_internal_id": "ASST_NON_TA386702255A8_1630"}, {"internal_id": 150204878, "Award ID": "TA386692255A6", "Award Amount": 7063106.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\nSTATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "083b4034-9a44-cecb-a431-8bc83f5db8de-C", "generated_internal_id": "ASST_NON_TA386692255A6_1630"}, {"internal_id": 150204879, "Award ID": "TA386682255A5", "Award Amount": 4389198.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\n STATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\n\n\nSUBRECIPIENT ACTIVITIES\nSUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "fbc091b5-34e1-6333-749e-42255d403853-C", "generated_internal_id": "ASST_NON_TA386682255A5_1630"}, {"internal_id": 150511184, "Award ID": "TA386672255A4", "Award Amount": 730393.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-15", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\nSTATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\n SUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AZ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "dde13409-0b46-f87d-3806-09fdf3ddf74d-C", "generated_internal_id": "ASST_NON_TA386672255A4_1630"}, {"internal_id": 150204880, "Award ID": "TA386662255A1", "Award Amount": 5293825.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2022-07-13", "CFDA Number": "17.245", "Description": "AWARD PURPOSE\nSTATES MAY USE THE TAA PROGRAM TAOA FUNDS PROVIDED UNDER THIS GRANT TO COVER THE COST OF RELATED STATE ADMINISTRATION AND THE PROVISION OF TRAINING, EMPLOYMENT AND CASE MANAGEMENT SERVICES, JOB SEARCH ALLOWANCES, AND RELOCATION ALLOWANCES TO ADVERSELY AFFECTED WORKERS. TEGL NO. 15-21, PROVIDES ADDITIONAL INFORMATION REGARDING THE USE AND PURPOSE OF TAA PROGRAM TAOA FUNDS.\n\nACTIVITIES PERFORMED\nTHE TAA FINAL RULE PUBLISHED IN THE FEDERAL REGISTER ON AUGUST 21, 2020, APPLICABLE STATUTES, AND GUIDANCE GOVERNING THE TAA PROGRAM DESCRIBE STATES' RESPONSIBILITIES AND SPECIFY THE ACTIVITIES STATES MUST PERFORM REGARDING THE USE OF TAA PROGRAM TAOA FUNDS.\n\nDELIVERABLES\nSTATES MUST USE TAA PROGRAM FUNDS PROVIDED UNDER THIS GRANT TO OPERATE THE TAA PROGRAM IN SUPPORT OF THE GOALS, OBJECTIVES, AND OUTCOMES PROVIDED IN THE FY 2022 FEDERAL UNEMPLOYMENT BENEFITS AND ALLOWANCES SECTION OF THE PRESIDENT'S ANNUAL BUDGET. \n\nINTENDED BENEFICIARY\nTAOA GRANT FUNDS ARE INTENDED TO SERVE ADVERSELY AFFECTED WORKERS, I.E., INDIVIDUALS WHO, BECAUSE OF LACK OF WORK IN ADVERSELY AFFECTED EMPLOYMENT, HAVE BEEN TOTALLY OR PARTIALLY SEPARATED FROM SUCH EMPLOYMENT; AND, ADVERSELY AFFECTED INCUMBENT WORKERS, (INDIVIDUALS WHO\u2014 (A) ARE MEMBERS OF A GROUP OF WORKERS WHO HAVE BEEN CERTIFIED AS ELIGIBLE TO APPLY FOR ADJUSTMENT ASSISTANCE UNDER SUBPART A; (B) HAVE NOT BEEN TOTALLY OR PARTIALLY SEPARATED FROM ADVERSELY AFFECTED EMPLOYMENT; AND (C) WORKERS FOR WHOM THE SECRETARY DETERMINES, ON AN INDIVIDUAL BASIS, ARE THREATENED WITH TOTAL OR PARTIAL SEPARATION).\n\nSUBRECIPIENT ACTIVITIES\n SUBRECIPIENT MEANS A NON-FEDERAL ENTITY OR FEDERAL AGENCY THAT RECEIVES A SUBAWARD FROM THE GRANT AWARD RECIPIENT UNDER THE TAOA FUNDS AWARD. SUBRECIPIENTS ARE ACCOUNTABLE TO THE GRANTEE FOR THE USE OF THE FEDERAL FUNDS PROVIDED BY THE SUBAWARD. SPECIFICATIONS OF SUBRECIPIENT ACTIVITIES AND THE REQUIREMENTS TO WHICH SUBRECIPIENTS MUST COMPLY, ARE SET OUT IN THE TAA ANNUAL FUNDING AGREEMENT, WHICH UPON GRANT AWARD, DOL SENDS TO EACH GRANTEE.", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "80952735-7086-41e5-7b86-e6901d05b705-C", "generated_internal_id": "ASST_NON_TA386662255A1_1630"}, {"internal_id": 138712827, "Award ID": "TA368112155A2", "Award Amount": 282845.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-07-26", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AK", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "dd9c0bbb-48d7-8e4e-2542-8f94d7cb2289-C", "generated_internal_id": "ASST_NON_TA368112155A2_1630"}, {"internal_id": 127923106, "Award ID": "TA361992155A56", "Award Amount": 151955.53, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-09", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "a4ee50e1-b77a-155f-5fe3-cedf30e05e1f-C", "generated_internal_id": "ASST_NON_TA361992155A56_1630"}, {"internal_id": 127923107, "Award ID": "TA361972155A10", "Award Amount": 200000.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-08", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "DE", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bbcd12b4-1518-9503-9648-0f08b880cc1b-C", "generated_internal_id": "ASST_NON_TA361972155A10_1630"}, {"internal_id": 127830514, "Award ID": "TA360832155A55", "Award Amount": 6840795.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-04", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7a7c092b-646d-1d43-0318-57b1f0f6b91d-C", "generated_internal_id": "ASST_NON_TA360832155A55_1630"}, {"internal_id": 128942275, "Award ID": "TA360822155A54", "Award Amount": 6240282.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WV", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "846a8e3f-aa4e-18cf-c266-755ef5d9cd3b-C", "generated_internal_id": "ASST_NON_TA360822155A54_1630"}, {"internal_id": 127830518, "Award ID": "TA360812155A53", "Award Amount": 23454131.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d32cbf7c-8ae1-2ea4-a158-a0c25c70233f-C", "generated_internal_id": "ASST_NON_TA360812155A53_1630"}, {"internal_id": 127830522, "Award ID": "TA360802155A51", "Award Amount": 8372390.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "cdf64453-c591-7dc4-091e-bcc8ce4b3bf8-C", "generated_internal_id": "ASST_NON_TA360802155A51_1630"}, {"internal_id": 127830515, "Award ID": "TA360792155A50", "Award Amount": 575103.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "188ec089-7e55-6993-1b6c-c45633c5c525-C", "generated_internal_id": "ASST_NON_TA360792155A50_1630"}, {"internal_id": 127830525, "Award ID": "TA360782155A49", "Award Amount": 6377072.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "UT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "884e85e0-5b57-c7bb-0320-0269c0f42caa-C", "generated_internal_id": "ASST_NON_TA360782155A49_1630"}, {"internal_id": 127830493, "Award ID": "TA360772155A48", "Award Amount": 18512885.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TX", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3f8e6ab8-83f5-3b05-d70f-d6922a8a565e-C", "generated_internal_id": "ASST_NON_TA360772155A48_1630"}, {"internal_id": 127830516, "Award ID": "TA360762155A47", "Award Amount": 5859942.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d15d67ff-9bea-1e97-7a91-c4da003d04dd-C", "generated_internal_id": "ASST_NON_TA360762155A47_1630"}, {"internal_id": 127830520, "Award ID": "TA360752155A46", "Award Amount": 2274005.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-04", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "SD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "359d1c64-c8d3-a5e4-434d-d7d7db0491f7-C", "generated_internal_id": "ASST_NON_TA360752155A46_1630"}, {"internal_id": 127830500, "Award ID": "TA360742155A45", "Award Amount": 7014650.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-04", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "SC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7c0ab944-f413-12ab-2f1d-8c8c0b402d24-C", "generated_internal_id": "ASST_NON_TA360742155A45_1630"}, {"internal_id": 127830503, "Award ID": "TA360732155A44", "Award Amount": 416136.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "RI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e9f0421d-cc22-21bc-7918-abb8af4d0be3-C", "generated_internal_id": "ASST_NON_TA360732155A44_1630"}, {"internal_id": 127830507, "Award ID": "TA360722155A42", "Award Amount": 28309992.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "67111aba-ca04-649d-f45a-abf9aa28596f-C", "generated_internal_id": "ASST_NON_TA360722155A42_1630"}, {"internal_id": 127830489, "Award ID": "TA360712155A41", "Award Amount": 26518505.47, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "62e0cef4-c2a9-4de9-d873-1e95838cc67a-C", "generated_internal_id": "ASST_NON_TA360712155A41_1630"}, {"internal_id": 127830517, "Award ID": "TA360702155A40", "Award Amount": 3609543.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OK", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ebe1d86a-aacd-3caf-cf00-6b8e6449590a-C", "generated_internal_id": "ASST_NON_TA360702155A40_1630"}, {"internal_id": 127830501, "Award ID": "TA360692155A39", "Award Amount": 22243508.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-04", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5328a709-be88-a95a-5c48-ac49aa83adc7-C", "generated_internal_id": "ASST_NON_TA360692155A39_1630"}, {"internal_id": 127830496, "Award ID": "TA360682155A38", "Award Amount": 438176.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "ND", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "00a02d4a-e0eb-059f-d8e6-01ce7c006005-C", "generated_internal_id": "ASST_NON_TA360682155A38_1630"}, {"internal_id": 127830521, "Award ID": "TA360672155A37", "Award Amount": 5680766.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "fa2f5127-5692-2c99-8d92-577968944beb-C", "generated_internal_id": "ASST_NON_TA360672155A37_1630"}, {"internal_id": 127830531, "Award ID": "TA360662155A36", "Award Amount": 12645785.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d2a390c1-d7aa-00da-1424-3e1044c081be-C", "generated_internal_id": "ASST_NON_TA360662155A36_1630"}, {"internal_id": 127830490, "Award ID": "TA360652155A35", "Award Amount": 5541713.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NM", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "468b6b30-c12b-6ee1-ab24-76a78077e304-C", "generated_internal_id": "ASST_NON_TA360652155A35_1630"}, {"internal_id": 127830529, "Award ID": "TA360642155A34", "Award Amount": 4932741.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NJ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bbaea497-1a7f-161c-51d7-d8f3c2deccbc-C", "generated_internal_id": "ASST_NON_TA360642155A34_1630"}, {"internal_id": 127830502, "Award ID": "TA360632155A33", "Award Amount": 851127.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "544f5a0a-2ccc-8ec6-6643-9ddd180c37d2-C", "generated_internal_id": "ASST_NON_TA360632155A33_1630"}, {"internal_id": 127830499, "Award ID": "TA360622155A32", "Award Amount": 752502.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NV", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c079e5d2-db3e-6b13-6c7c-407a8c93521d-C", "generated_internal_id": "ASST_NON_TA360622155A32_1630"}, {"internal_id": 127830512, "Award ID": "TA360612155A31", "Award Amount": 1721602.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-04", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NE", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "53560a59-1ae6-832d-6db5-3082a56389d5-C", "generated_internal_id": "ASST_NON_TA360612155A31_1630"}, {"internal_id": 127830508, "Award ID": "TA360602155A30", "Award Amount": 235427.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "417d25ce-8d31-fb9d-8657-44dc385f39ad-C", "generated_internal_id": "ASST_NON_TA360602155A30_1630"}, {"internal_id": 127830511, "Award ID": "TA360592155A29", "Award Amount": 8490058.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-04", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "834c7a17-8afe-ef5c-f974-d4c78b3792cd-C", "generated_internal_id": "ASST_NON_TA360592155A29_1630"}, {"internal_id": 127830510, "Award ID": "TA360582155A28", "Award Amount": 440437.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "46c9f5fc-0124-8f41-debf-f89950f1ab76-C", "generated_internal_id": "ASST_NON_TA360582155A28_1630"}, {"internal_id": 127830524, "Award ID": "TA360572155A27", "Award Amount": 13097018.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-04", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "260ed1ea-1ea9-d6d1-bb92-39df0506ff29-C", "generated_internal_id": "ASST_NON_TA360572155A27_1630"}, {"internal_id": 127830533, "Award ID": "TA360562155A26", "Award Amount": 9875280.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-04", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8d56c54c-3c4f-9ba5-e713-5968374ddaac-C", "generated_internal_id": "ASST_NON_TA360562155A26_1630"}, {"internal_id": 127830498, "Award ID": "TA360552155A25", "Award Amount": 11516934.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "21d393fd-60ea-cec2-1d82-d7c447633702-C", "generated_internal_id": "ASST_NON_TA360552155A25_1630"}, {"internal_id": 127830494, "Award ID": "TA360542155A24", "Award Amount": 4079197.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "4d13a910-0420-2522-e502-49372f5c39e6-C", "generated_internal_id": "ASST_NON_TA360542155A24_1630"}, {"internal_id": 127830492, "Award ID": "TA360532155A23", "Award Amount": 549583.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "ME", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "de5f8d9c-db27-6631-fde3-7b4268a955ef-C", "generated_internal_id": "ASST_NON_TA360532155A23_1630"}, {"internal_id": 127830495, "Award ID": "TA360522155A22", "Award Amount": 1148816.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "LA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "610cdfe0-3bf4-21f8-d433-352dba7157e7-C", "generated_internal_id": "ASST_NON_TA360522155A22_1630"}, {"internal_id": 127830506, "Award ID": "TA360512155A21", "Award Amount": 7289601.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9594ad8f-777a-01e4-21cc-02c0438e9a13-C", "generated_internal_id": "ASST_NON_TA360512155A21_1630"}, {"internal_id": 127830528, "Award ID": "TA360502155A20", "Award Amount": 13594228.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-04", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f956af53-7594-bbbb-8c21-e83b2595618e-C", "generated_internal_id": "ASST_NON_TA360502155A20_1630"}, {"internal_id": 127830505, "Award ID": "TA360492155A19", "Award Amount": 5152690.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "38945dff-1d01-d124-868e-296e9cd4b40e-C", "generated_internal_id": "ASST_NON_TA360492155A19_1630"}, {"internal_id": 127830509, "Award ID": "TA360482155A18", "Award Amount": 16304596.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "55a913e6-c7a1-e3ab-3504-a525657ec61b-C", "generated_internal_id": "ASST_NON_TA360482155A18_1630"}, {"internal_id": 127830526, "Award ID": "TA360472155A17", "Award Amount": 15628021.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "49c0b4a8-3274-5dbf-bfdc-21abf88201aa-C", "generated_internal_id": "ASST_NON_TA360472155A17_1630"}, {"internal_id": 127830497, "Award ID": "TA360462155A16", "Award Amount": 1888865.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "ID", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c5fe910a-7613-4d8e-4231-e321fb6900ba-C", "generated_internal_id": "ASST_NON_TA360462155A16_1630"}, {"internal_id": 127830532, "Award ID": "TA360452155A15", "Award Amount": 154445.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "HI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "b07eb7d7-3b40-4ce5-2970-f82ed238243f-C", "generated_internal_id": "ASST_NON_TA360452155A15_1630"}, {"internal_id": 127830491, "Award ID": "TA360442155A13", "Award Amount": 6646085.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "GA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c9860cdb-a017-dfc7-57ec-e362225694da-C", "generated_internal_id": "ASST_NON_TA360442155A13_1630"}, {"internal_id": 127830527, "Award ID": "TA360432155A12", "Award Amount": 3877009.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "aca7fa8c-c5aa-0d3d-29a6-e143b50b9fa4-C", "generated_internal_id": "ASST_NON_TA360432155A12_1630"}, {"internal_id": 127830530, "Award ID": "TA360422155A9", "Award Amount": 4609448.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "97c80fbf-3298-005f-f24e-73a8b1fd9edb-C", "generated_internal_id": "ASST_NON_TA360422155A9_1630"}, {"internal_id": 127830504, "Award ID": "TA360412155A8", "Award Amount": 2711860.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7ec1af8f-4c5f-a77c-1a5b-21acb44aa1dc-C", "generated_internal_id": "ASST_NON_TA360412155A8_1630"}, {"internal_id": 127830523, "Award ID": "TA360402155A6", "Award Amount": 30333349.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "083b4034-9a44-cecb-a431-8bc83f5db8de-C", "generated_internal_id": "ASST_NON_TA360402155A6_1630"}, {"internal_id": 127830513, "Award ID": "TA360392155A5", "Award Amount": 5169828.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "fbc091b5-34e1-6333-749e-42255d403853-C", "generated_internal_id": "ASST_NON_TA360392155A5_1630"}, {"internal_id": 127830519, "Award ID": "TA360382155A4", "Award Amount": 1895221.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AZ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "dde13409-0b46-f87d-3806-09fdf3ddf74d-C", "generated_internal_id": "ASST_NON_TA360382155A4_1630"}, {"internal_id": 127830534, "Award ID": "TA360372155A1", "Award Amount": 5978652.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2021-03-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "80952735-7086-41e5-7b86-e6901d05b705-C", "generated_internal_id": "ASST_NON_TA360372155A1_1630"}, {"internal_id": 95464768, "Award ID": "TA344792055A56", "Award Amount": 36995.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-02-21", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "a4ee50e1-b77a-155f-5fe3-cedf30e05e1f-C", "generated_internal_id": "ASST_NON_TA344792055A56_1630"}, {"internal_id": 98429466, "Award ID": "TA344782055A55", "Award Amount": 6031610.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-23", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7a7c092b-646d-1d43-0318-57b1f0f6b91d-C", "generated_internal_id": "ASST_NON_TA344782055A55_1630"}, {"internal_id": 98429465, "Award ID": "TA344772055A54", "Award Amount": 9159094.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-23", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WV", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "846a8e3f-aa4e-18cf-c266-755ef5d9cd3b-C", "generated_internal_id": "ASST_NON_TA344772055A54_1630"}, {"internal_id": 98429464, "Award ID": "TA344762055A53", "Award Amount": 18162888.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-24", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d32cbf7c-8ae1-2ea4-a158-a0c25c70233f-C", "generated_internal_id": "ASST_NON_TA344762055A53_1630"}, {"internal_id": 98429463, "Award ID": "TA344752055A51", "Award Amount": 11184184.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-23", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "cdf64453-c591-7dc4-091e-bcc8ce4b3bf8-C", "generated_internal_id": "ASST_NON_TA344752055A51_1630"}, {"internal_id": 98429462, "Award ID": "TA344742055A50", "Award Amount": 908261.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-24", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "188ec089-7e55-6993-1b6c-c45633c5c525-C", "generated_internal_id": "ASST_NON_TA344742055A50_1630"}, {"internal_id": 98429461, "Award ID": "TA344732055A49", "Award Amount": 3290101.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-22", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "UT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "884e85e0-5b57-c7bb-0320-0269c0f42caa-C", "generated_internal_id": "ASST_NON_TA344732055A49_1630"}, {"internal_id": 98429460, "Award ID": "TA344722055A48", "Award Amount": 21445067.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-22", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TX", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3f8e6ab8-83f5-3b05-d70f-d6922a8a565e-C", "generated_internal_id": "ASST_NON_TA344722055A48_1630"}, {"internal_id": 98429459, "Award ID": "TA344712055A47", "Award Amount": 6213192.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-22", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d15d67ff-9bea-1e97-7a91-c4da003d04dd-C", "generated_internal_id": "ASST_NON_TA344712055A47_1630"}, {"internal_id": 98566425, "Award ID": "TA344702055A46", "Award Amount": 616684.99, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-30", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "SD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "359d1c64-c8d3-a5e4-434d-d7d7db0491f7-C", "generated_internal_id": "ASST_NON_TA344702055A46_1630"}, {"internal_id": 103564286, "Award ID": "TA344692055A45", "Award Amount": 1287298.5, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-07-15", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "SC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7c0ab944-f413-12ab-2f1d-8c8c0b402d24-C", "generated_internal_id": "ASST_NON_TA344692055A45_1630"}, {"internal_id": 98429458, "Award ID": "TA344682055A44", "Award Amount": 648550.09, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-26", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "RI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e9f0421d-cc22-21bc-7918-abb8af4d0be3-C", "generated_internal_id": "ASST_NON_TA344682055A44_1630"}, {"internal_id": 98429457, "Award ID": "TA344672055A72", "Award Amount": 155195.68, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-24", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8e5e253b-7d1e-bd25-2657-ed39b259a96f-C", "generated_internal_id": "ASST_NON_TA344672055A72_1630"}, {"internal_id": 98429456, "Award ID": "TA344662055A42", "Award Amount": 19523680.25, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-23", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "67111aba-ca04-649d-f45a-abf9aa28596f-C", "generated_internal_id": "ASST_NON_TA344662055A42_1630"}, {"internal_id": 98429455, "Award ID": "TA344652055A41", "Award Amount": 27017697.64, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-25", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "62e0cef4-c2a9-4de9-d873-1e95838cc67a-C", "generated_internal_id": "ASST_NON_TA344652055A41_1630"}, {"internal_id": 98429454, "Award ID": "TA344642055A40", "Award Amount": 1795324.31, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-26", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OK", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ebe1d86a-aacd-3caf-cf00-6b8e6449590a-C", "generated_internal_id": "ASST_NON_TA344642055A40_1630"}, {"internal_id": 98429453, "Award ID": "TA344632055A39", "Award Amount": 19182468.55, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-23", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5328a709-be88-a95a-5c48-ac49aa83adc7-C", "generated_internal_id": "ASST_NON_TA344632055A39_1630"}, {"internal_id": 98429452, "Award ID": "TA344622055A38", "Award Amount": 751182.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-22", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "ND", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "00a02d4a-e0eb-059f-d8e6-01ce7c006005-C", "generated_internal_id": "ASST_NON_TA344622055A38_1630"}, {"internal_id": 103564285, "Award ID": "TA344612055A37", "Award Amount": 7446590.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-07-15", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "fa2f5127-5692-2c99-8d92-577968944beb-C", "generated_internal_id": "ASST_NON_TA344612055A37_1630"}, {"internal_id": 98429451, "Award ID": "TA344602055A36", "Award Amount": 15383748.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-24", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d2a390c1-d7aa-00da-1424-3e1044c081be-C", "generated_internal_id": "ASST_NON_TA344602055A36_1630"}, {"internal_id": 98429450, "Award ID": "TA344592055A35", "Award Amount": 3723259.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-22", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NM", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "468b6b30-c12b-6ee1-ab24-76a78077e304-C", "generated_internal_id": "ASST_NON_TA344592055A35_1630"}, {"internal_id": 98429449, "Award ID": "TA344582055A34", "Award Amount": 6788031.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-24", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NJ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bbaea497-1a7f-161c-51d7-d8f3c2deccbc-C", "generated_internal_id": "ASST_NON_TA344582055A34_1630"}, {"internal_id": 98566409, "Award ID": "TA344572055A33", "Award Amount": 1177525.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-30", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "544f5a0a-2ccc-8ec6-6643-9ddd180c37d2-C", "generated_internal_id": "ASST_NON_TA344572055A33_1630"}, {"internal_id": 98429448, "Award ID": "TA344552055A31", "Award Amount": 2137481.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-23", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NE", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "53560a59-1ae6-832d-6db5-3082a56389d5-C", "generated_internal_id": "ASST_NON_TA344552055A31_1630"}, {"internal_id": 98566403, "Award ID": "TA344542055A30", "Award Amount": 381564.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-29", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "417d25ce-8d31-fb9d-8657-44dc385f39ad-C", "generated_internal_id": "ASST_NON_TA344542055A30_1630"}, {"internal_id": 98429447, "Award ID": "TA344532055A29", "Award Amount": 11903847.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-23", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "834c7a17-8afe-ef5c-f974-d4c78b3792cd-C", "generated_internal_id": "ASST_NON_TA344532055A29_1630"}, {"internal_id": 98429446, "Award ID": "TA344522055A28", "Award Amount": 969083.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-22", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "46c9f5fc-0124-8f41-debf-f89950f1ab76-C", "generated_internal_id": "ASST_NON_TA344522055A28_1630"}, {"internal_id": 98429445, "Award ID": "TA344512055A27", "Award Amount": 12331798.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-23", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "260ed1ea-1ea9-d6d1-bb92-39df0506ff29-C", "generated_internal_id": "ASST_NON_TA344512055A27_1630"}, {"internal_id": 98429444, "Award ID": "TA344502055A26", "Award Amount": 12825482.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-25", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8d56c54c-3c4f-9ba5-e713-5968374ddaac-C", "generated_internal_id": "ASST_NON_TA344502055A26_1630"}, {"internal_id": 107039685, "Award ID": "TA344492055A25", "Award Amount": 14331207.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-07-21", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "21d393fd-60ea-cec2-1d82-d7c447633702-C", "generated_internal_id": "ASST_NON_TA344492055A25_1630"}, {"internal_id": 98429443, "Award ID": "TA344482055A24", "Award Amount": 3616827.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-23", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "4d13a910-0420-2522-e502-49372f5c39e6-C", "generated_internal_id": "ASST_NON_TA344482055A24_1630"}, {"internal_id": 98429442, "Award ID": "TA344472055A23", "Award Amount": 1399650.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-24", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "ME", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "de5f8d9c-db27-6631-fde3-7b4268a955ef-C", "generated_internal_id": "ASST_NON_TA344472055A23_1630"}, {"internal_id": 98429441, "Award ID": "TA344462055A22", "Award Amount": 882206.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-22", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "LA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "610cdfe0-3bf4-21f8-d433-352dba7157e7-C", "generated_internal_id": "ASST_NON_TA344462055A22_1630"}, {"internal_id": 98429440, "Award ID": "TA344452055A21", "Award Amount": 2075847.17, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-22", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c9b235a4-318b-92b9-ecd8-11114346eeb0-C", "generated_internal_id": "ASST_NON_TA344452055A21_1630"}, {"internal_id": 98429439, "Award ID": "TA344442055A20", "Award Amount": 4823292.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-23", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f956af53-7594-bbbb-8c21-e83b2595618e-C", "generated_internal_id": "ASST_NON_TA344442055A20_1630"}, {"internal_id": 98429438, "Award ID": "TA344432055A19", "Award Amount": 6326653.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-23", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "38945dff-1d01-d124-868e-296e9cd4b40e-C", "generated_internal_id": "ASST_NON_TA344432055A19_1630"}, {"internal_id": 98429437, "Award ID": "TA344422055A18", "Award Amount": 4741095.37, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-23", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "55a913e6-c7a1-e3ab-3504-a525657ec61b-C", "generated_internal_id": "ASST_NON_TA344422055A18_1630"}, {"internal_id": 98429436, "Award ID": "TA344412055A17", "Award Amount": 19350065.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-23", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "49c0b4a8-3274-5dbf-bfdc-21abf88201aa-C", "generated_internal_id": "ASST_NON_TA344412055A17_1630"}, {"internal_id": 98429435, "Award ID": "TA344402055A16", "Award Amount": 417967.82, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-25", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "ID", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c5fe910a-7613-4d8e-4231-e321fb6900ba-C", "generated_internal_id": "ASST_NON_TA344402055A16_1630"}, {"internal_id": 98429434, "Award ID": "TA344392055A15", "Award Amount": 276274.42, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-24", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "HI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "b07eb7d7-3b40-4ce5-2970-f82ed238243f-C", "generated_internal_id": "ASST_NON_TA344392055A15_1630"}, {"internal_id": 103564281, "Award ID": "TA344382055A13", "Award Amount": 10076907.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-07-16", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "GA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c9860cdb-a017-dfc7-57ec-e362225694da-C", "generated_internal_id": "ASST_NON_TA344382055A13_1630"}, {"internal_id": 98429433, "Award ID": "TA344372055A12", "Award Amount": 6406473.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-22", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "aca7fa8c-c5aa-0d3d-29a6-e143b50b9fa4-C", "generated_internal_id": "ASST_NON_TA344372055A12_1630"}, {"internal_id": 98429432, "Award ID": "TA344352055A9", "Award Amount": 8036593.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-24", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "97c80fbf-3298-005f-f24e-73a8b1fd9edb-C", "generated_internal_id": "ASST_NON_TA344352055A9_1630"}, {"internal_id": 98429431, "Award ID": "TA344342055A8", "Award Amount": 3553247.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-22", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7ec1af8f-4c5f-a77c-1a5b-21acb44aa1dc-C", "generated_internal_id": "ASST_NON_TA344342055A8_1630"}, {"internal_id": 98429430, "Award ID": "TA344332055A6", "Award Amount": 38805129.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-24", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "083b4034-9a44-cecb-a431-8bc83f5db8de-C", "generated_internal_id": "ASST_NON_TA344332055A6_1630"}, {"internal_id": 98429429, "Award ID": "TA344322055A5", "Award Amount": 5578136.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-22", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "fbc091b5-34e1-6333-749e-42255d403853-C", "generated_internal_id": "ASST_NON_TA344322055A5_1630"}, {"internal_id": 98429428, "Award ID": "TA344312055A4", "Award Amount": 1490867.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-24", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AZ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "dde13409-0b46-f87d-3806-09fdf3ddf74d-C", "generated_internal_id": "ASST_NON_TA344312055A4_1630"}, {"internal_id": 98429427, "Award ID": "TA344292055A1", "Award Amount": 2869065.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2020-06-22", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "80952735-7086-41e5-7b86-e6901d05b705-C", "generated_internal_id": "ASST_NON_TA344292055A1_1630"}, {"internal_id": 80251244, "Award ID": "TA326861955A55", "Award Amount": 3909798.94, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7a7c092b-646d-1d43-0318-57b1f0f6b91d-C", "generated_internal_id": "ASST_NON_TA326861955A55_1630"}, {"internal_id": 80251243, "Award ID": "TA326851955A54", "Award Amount": 2096006.55, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WV", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "846a8e3f-aa4e-18cf-c266-755ef5d9cd3b-C", "generated_internal_id": "ASST_NON_TA326851955A54_1630"}, {"internal_id": 80251242, "Award ID": "TA326841955A53", "Award Amount": 13899325.56, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d32cbf7c-8ae1-2ea4-a158-a0c25c70233f-C", "generated_internal_id": "ASST_NON_TA326841955A53_1630"}, {"internal_id": 80251241, "Award ID": "TA326831955A51", "Award Amount": 3583386.49, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "cdf64453-c591-7dc4-091e-bcc8ce4b3bf8-C", "generated_internal_id": "ASST_NON_TA326831955A51_1630"}, {"internal_id": 80251240, "Award ID": "TA326821955A50", "Award Amount": 254825.12, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "188ec089-7e55-6993-1b6c-c45633c5c525-C", "generated_internal_id": "ASST_NON_TA326821955A50_1630"}, {"internal_id": 80251239, "Award ID": "TA326811955A49", "Award Amount": 559746.57, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "UT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "884e85e0-5b57-c7bb-0320-0269c0f42caa-C", "generated_internal_id": "ASST_NON_TA326811955A49_1630"}, {"internal_id": 80251238, "Award ID": "TA326801955A48", "Award Amount": 6166183.4, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TX", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3f8e6ab8-83f5-3b05-d70f-d6922a8a565e-C", "generated_internal_id": "ASST_NON_TA326801955A48_1630"}, {"internal_id": 80251237, "Award ID": "TA326791955A47", "Award Amount": 1708602.8, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d15d67ff-9bea-1e97-7a91-c4da003d04dd-C", "generated_internal_id": "ASST_NON_TA326791955A47_1630"}, {"internal_id": 80251236, "Award ID": "TA326781955A46", "Award Amount": 699547.26, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-12", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "SD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "359d1c64-c8d3-a5e4-434d-d7d7db0491f7-C", "generated_internal_id": "ASST_NON_TA326781955A46_1630"}, {"internal_id": 80251235, "Award ID": "TA326771955A45", "Award Amount": 1862493.56, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "SC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7c0ab944-f413-12ab-2f1d-8c8c0b402d24-C", "generated_internal_id": "ASST_NON_TA326771955A45_1630"}, {"internal_id": 80251234, "Award ID": "TA326761955A44", "Award Amount": 1008399.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "RI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e9f0421d-cc22-21bc-7918-abb8af4d0be3-C", "generated_internal_id": "ASST_NON_TA326761955A44_1630"}, {"internal_id": 80251233, "Award ID": "TA326751955A72", "Award Amount": 221979.48, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8e5e253b-7d1e-bd25-2657-ed39b259a96f-C", "generated_internal_id": "ASST_NON_TA326751955A72_1630"}, {"internal_id": 80251232, "Award ID": "TA326741955A42", "Award Amount": 22250988.41, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "67111aba-ca04-649d-f45a-abf9aa28596f-C", "generated_internal_id": "ASST_NON_TA326741955A42_1630"}, {"internal_id": 80251231, "Award ID": "TA326731955A41", "Award Amount": 12836571.01, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "62e0cef4-c2a9-4de9-d873-1e95838cc67a-C", "generated_internal_id": "ASST_NON_TA326731955A41_1630"}, {"internal_id": 80251230, "Award ID": "TA326721955A40", "Award Amount": 1546665.55, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OK", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ebe1d86a-aacd-3caf-cf00-6b8e6449590a-C", "generated_internal_id": "ASST_NON_TA326721955A40_1630"}, {"internal_id": 80251229, "Award ID": "TA326711955A39", "Award Amount": 21663706.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5328a709-be88-a95a-5c48-ac49aa83adc7-C", "generated_internal_id": "ASST_NON_TA326711955A39_1630"}, {"internal_id": 80251228, "Award ID": "TA326701955A38", "Award Amount": 260840.5, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "ND", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "00a02d4a-e0eb-059f-d8e6-01ce7c006005-C", "generated_internal_id": "ASST_NON_TA326701955A38_1630"}, {"internal_id": 80251227, "Award ID": "TA326691955A37", "Award Amount": 2520584.12, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "fa2f5127-5692-2c99-8d92-577968944beb-C", "generated_internal_id": "ASST_NON_TA326691955A37_1630"}, {"internal_id": 80251226, "Award ID": "TA326681955A36", "Award Amount": 4328003.21, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d2a390c1-d7aa-00da-1424-3e1044c081be-C", "generated_internal_id": "ASST_NON_TA326681955A36_1630"}, {"internal_id": 80251225, "Award ID": "TA326671955A35", "Award Amount": 2222077.71, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NM", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "468b6b30-c12b-6ee1-ab24-76a78077e304-C", "generated_internal_id": "ASST_NON_TA326671955A35_1630"}, {"internal_id": 79639605, "Award ID": "TA326661955A34", "Award Amount": 1877593.33, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-03-18", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NJ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bbaea497-1a7f-161c-51d7-d8f3c2deccbc-C", "generated_internal_id": "ASST_NON_TA326661955A34_1630"}, {"internal_id": 80251224, "Award ID": "TA326651955A33", "Award Amount": 469269.54, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "544f5a0a-2ccc-8ec6-6643-9ddd180c37d2-C", "generated_internal_id": "ASST_NON_TA326651955A33_1630"}, {"internal_id": 81159514, "Award ID": "TA326641955A32", "Award Amount": 88823.59, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-05-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NV", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c079e5d2-db3e-6b13-6c7c-407a8c93521d-C", "generated_internal_id": "ASST_NON_TA326641955A32_1630"}, {"internal_id": 80251223, "Award ID": "TA326631955A31", "Award Amount": 696984.5, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NE", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "53560a59-1ae6-832d-6db5-3082a56389d5-C", "generated_internal_id": "ASST_NON_TA326631955A31_1630"}, {"internal_id": 80251222, "Award ID": "TA326621955A30", "Award Amount": 155607.56, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "417d25ce-8d31-fb9d-8657-44dc385f39ad-C", "generated_internal_id": "ASST_NON_TA326621955A30_1630"}, {"internal_id": 80251221, "Award ID": "TA326611955A29", "Award Amount": 2650500.91, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "834c7a17-8afe-ef5c-f974-d4c78b3792cd-C", "generated_internal_id": "ASST_NON_TA326611955A29_1630"}, {"internal_id": 80251220, "Award ID": "TA326601955A28", "Award Amount": 158105.55, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "46c9f5fc-0124-8f41-debf-f89950f1ab76-C", "generated_internal_id": "ASST_NON_TA326601955A28_1630"}, {"internal_id": 80251219, "Award ID": "TA326591955A27", "Award Amount": 4601288.58, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "260ed1ea-1ea9-d6d1-bb92-39df0506ff29-C", "generated_internal_id": "ASST_NON_TA326591955A27_1630"}, {"internal_id": 80251218, "Award ID": "TA326581955A26", "Award Amount": 6284728.09, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8d56c54c-3c4f-9ba5-e713-5968374ddaac-C", "generated_internal_id": "ASST_NON_TA326581955A26_1630"}, {"internal_id": 80251217, "Award ID": "TA326571955A25", "Award Amount": 5584914.85, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "21d393fd-60ea-cec2-1d82-d7c447633702-C", "generated_internal_id": "ASST_NON_TA326571955A25_1630"}, {"internal_id": 80251216, "Award ID": "TA326561955A24", "Award Amount": 1743205.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "4d13a910-0420-2522-e502-49372f5c39e6-C", "generated_internal_id": "ASST_NON_TA326561955A24_1630"}, {"internal_id": 80251215, "Award ID": "TA326551955A23", "Award Amount": 744193.88, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-02", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "ME", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "de5f8d9c-db27-6631-fde3-7b4268a955ef-C", "generated_internal_id": "ASST_NON_TA326551955A23_1630"}, {"internal_id": 80251214, "Award ID": "TA326541955A22", "Award Amount": 944070.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-01", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "LA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "610cdfe0-3bf4-21f8-d433-352dba7157e7-C", "generated_internal_id": "ASST_NON_TA326541955A22_1630"}, {"internal_id": 81159513, "Award ID": "TA326531955A21", "Award Amount": 2471783.73, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-05-22", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9594ad8f-777a-01e4-21cc-02c0438e9a13-C", "generated_internal_id": "ASST_NON_TA326531955A21_1630"}, {"internal_id": 80251213, "Award ID": "TA326521955A20", "Award Amount": 3637514.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-01", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f956af53-7594-bbbb-8c21-e83b2595618e-C", "generated_internal_id": "ASST_NON_TA326521955A20_1630"}, {"internal_id": 80251212, "Award ID": "TA326511955A19", "Award Amount": 1749663.13, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-01", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "38945dff-1d01-d124-868e-296e9cd4b40e-C", "generated_internal_id": "ASST_NON_TA326511955A19_1630"}, {"internal_id": 80251211, "Award ID": "TA326501955A18", "Award Amount": 5698696.02, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-01", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "55a913e6-c7a1-e3ab-3504-a525657ec61b-C", "generated_internal_id": "ASST_NON_TA326501955A18_1630"}, {"internal_id": 80251210, "Award ID": "TA326491955A17", "Award Amount": 5336728.59, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-01", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "49c0b4a8-3274-5dbf-bfdc-21abf88201aa-C", "generated_internal_id": "ASST_NON_TA326491955A17_1630"}, {"internal_id": 80251209, "Award ID": "TA326481955A16", "Award Amount": 581526.22, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-01", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "ID", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c5fe910a-7613-4d8e-4231-e321fb6900ba-C", "generated_internal_id": "ASST_NON_TA326481955A16_1630"}, {"internal_id": 80251208, "Award ID": "TA326471955A15", "Award Amount": 480684.64, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-12", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "HI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "b07eb7d7-3b40-4ce5-2970-f82ed238243f-C", "generated_internal_id": "ASST_NON_TA326471955A15_1630"}, {"internal_id": 80251207, "Award ID": "TA326461955A13", "Award Amount": 4843281.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-01", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "GA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c9860cdb-a017-dfc7-57ec-e362225694da-C", "generated_internal_id": "ASST_NON_TA326461955A13_1630"}, {"internal_id": 80251206, "Award ID": "TA326451955A12", "Award Amount": 1901027.4, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-01", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "aca7fa8c-c5aa-0d3d-29a6-e143b50b9fa4-C", "generated_internal_id": "ASST_NON_TA326451955A12_1630"}, {"internal_id": 80251205, "Award ID": "TA326431955A9", "Award Amount": 4966073.64, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-01", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "97c80fbf-3298-005f-f24e-73a8b1fd9edb-C", "generated_internal_id": "ASST_NON_TA326431955A9_1630"}, {"internal_id": 80251204, "Award ID": "TA326421955A8", "Award Amount": 1598194.96, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-01", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7ec1af8f-4c5f-a77c-1a5b-21acb44aa1dc-C", "generated_internal_id": "ASST_NON_TA326421955A8_1630"}, {"internal_id": 80251203, "Award ID": "TA326411955A6", "Award Amount": 11225878.17, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-01", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "083b4034-9a44-cecb-a431-8bc83f5db8de-C", "generated_internal_id": "ASST_NON_TA326411955A6_1630"}, {"internal_id": 80251202, "Award ID": "TA326401955A5", "Award Amount": 2371252.88, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-04-01", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "fbc091b5-34e1-6333-749e-42255d403853-C", "generated_internal_id": "ASST_NON_TA326401955A5_1630"}, {"internal_id": 79639604, "Award ID": "TA326391955A4", "Award Amount": 818822.96, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-03-29", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AZ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "dde13409-0b46-f87d-3806-09fdf3ddf74d-C", "generated_internal_id": "ASST_NON_TA326391955A4_1630"}, {"internal_id": 79639603, "Award ID": "TA326371955A1", "Award Amount": 2012414.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2019-03-29", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "80952735-7086-41e5-7b86-e6901d05b705-C", "generated_internal_id": "ASST_NON_TA326371955A1_1630"}, {"internal_id": 67440123, "Award ID": "TA317331855A55", "Award Amount": 2375939.1, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-12", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7a7c092b-646d-1d43-0318-57b1f0f6b91d-C", "generated_internal_id": "ASST_NON_TA317331855A55_1630"}, {"internal_id": 67440124, "Award ID": "TA317321855A54", "Award Amount": 3548524.64, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-09", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WV", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "846a8e3f-aa4e-18cf-c266-755ef5d9cd3b-C", "generated_internal_id": "ASST_NON_TA317321855A54_1630"}, {"internal_id": 67440125, "Award ID": "TA317311855A53", "Award Amount": 8505288.61, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d32cbf7c-8ae1-2ea4-a158-a0c25c70233f-C", "generated_internal_id": "ASST_NON_TA317311855A53_1630"}, {"internal_id": 67440126, "Award ID": "TA317301855A51", "Award Amount": 2353394.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-12", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "cdf64453-c591-7dc4-091e-bcc8ce4b3bf8-C", "generated_internal_id": "ASST_NON_TA317301855A51_1630"}, {"internal_id": 67440127, "Award ID": "TA317291855A50", "Award Amount": 368432.54, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "188ec089-7e55-6993-1b6c-c45633c5c525-C", "generated_internal_id": "ASST_NON_TA317291855A50_1630"}, {"internal_id": 67440128, "Award ID": "TA317281855A49", "Award Amount": 915549.87, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-12", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "UT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "884e85e0-5b57-c7bb-0320-0269c0f42caa-C", "generated_internal_id": "ASST_NON_TA317281855A49_1630"}, {"internal_id": 67440129, "Award ID": "TA317271855A48", "Award Amount": 6967674.03, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-09", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TX", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3f8e6ab8-83f5-3b05-d70f-d6922a8a565e-C", "generated_internal_id": "ASST_NON_TA317271855A48_1630"}, {"internal_id": 67440130, "Award ID": "TA317261855A47", "Award Amount": 2136648.58, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-06", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d15d67ff-9bea-1e97-7a91-c4da003d04dd-C", "generated_internal_id": "ASST_NON_TA317261855A47_1630"}, {"internal_id": 67440131, "Award ID": "TA317251855A46", "Award Amount": 754313.1, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-09", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "SD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "359d1c64-c8d3-a5e4-434d-d7d7db0491f7-C", "generated_internal_id": "ASST_NON_TA317251855A46_1630"}, {"internal_id": 67440132, "Award ID": "TA317241855A45", "Award Amount": 3208948.33, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-13", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "SC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7c0ab944-f413-12ab-2f1d-8c8c0b402d24-C", "generated_internal_id": "ASST_NON_TA317241855A45_1630"}, {"internal_id": 67440133, "Award ID": "TA317231855A44", "Award Amount": 1298821.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-06", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "RI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e9f0421d-cc22-21bc-7918-abb8af4d0be3-C", "generated_internal_id": "ASST_NON_TA317231855A44_1630"}, {"internal_id": 67440134, "Award ID": "TA317221855A72", "Award Amount": 152923.76, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-09", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8e5e253b-7d1e-bd25-2657-ed39b259a96f-C", "generated_internal_id": "ASST_NON_TA317221855A72_1630"}, {"internal_id": 67440135, "Award ID": "TA317211855A42", "Award Amount": 19627695.53, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-13", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "67111aba-ca04-649d-f45a-abf9aa28596f-C", "generated_internal_id": "ASST_NON_TA317211855A42_1630"}, {"internal_id": 67440136, "Award ID": "TA317201855A41", "Award Amount": 12642177.13, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-06", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "62e0cef4-c2a9-4de9-d873-1e95838cc67a-C", "generated_internal_id": "ASST_NON_TA317201855A41_1630"}, {"internal_id": 67440137, "Award ID": "TA317191855A40", "Award Amount": 1884984.07, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-09", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OK", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ebe1d86a-aacd-3caf-cf00-6b8e6449590a-C", "generated_internal_id": "ASST_NON_TA317191855A40_1630"}, {"internal_id": 67440138, "Award ID": "TA317181855A39", "Award Amount": 14447163.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-09", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5328a709-be88-a95a-5c48-ac49aa83adc7-C", "generated_internal_id": "ASST_NON_TA317181855A39_1630"}, {"internal_id": 67440139, "Award ID": "TA317171855A37", "Award Amount": 2373812.82, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-03", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "fa2f5127-5692-2c99-8d92-577968944beb-C", "generated_internal_id": "ASST_NON_TA317171855A37_1630"}, {"internal_id": 67440140, "Award ID": "TA317161855A35", "Award Amount": 1553886.34, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-09", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NM", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "468b6b30-c12b-6ee1-ab24-76a78077e304-C", "generated_internal_id": "ASST_NON_TA317161855A35_1630"}, {"internal_id": 67440141, "Award ID": "TA317151855A36", "Award Amount": 4852634.81, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-13", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d2a390c1-d7aa-00da-1424-3e1044c081be-C", "generated_internal_id": "ASST_NON_TA317151855A36_1630"}, {"internal_id": 67440142, "Award ID": "TA317141855A34", "Award Amount": 4173090.24, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-09", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NJ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bbaea497-1a7f-161c-51d7-d8f3c2deccbc-C", "generated_internal_id": "ASST_NON_TA317141855A34_1630"}, {"internal_id": 67440143, "Award ID": "TA317131855A33", "Award Amount": 568834.76, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-06", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "544f5a0a-2ccc-8ec6-6643-9ddd180c37d2-C", "generated_internal_id": "ASST_NON_TA317131855A33_1630"}, {"internal_id": 67440144, "Award ID": "TA317111855A31", "Award Amount": 866074.74, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-06", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NE", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "53560a59-1ae6-832d-6db5-3082a56389d5-C", "generated_internal_id": "ASST_NON_TA317111855A31_1630"}, {"internal_id": 67440145, "Award ID": "TA317101855A30", "Award Amount": 254752.28, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-09", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "417d25ce-8d31-fb9d-8657-44dc385f39ad-C", "generated_internal_id": "ASST_NON_TA317101855A30_1630"}, {"internal_id": 67440146, "Award ID": "TA317091855A29", "Award Amount": 3427215.4, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-09", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "834c7a17-8afe-ef5c-f974-d4c78b3792cd-C", "generated_internal_id": "ASST_NON_TA317091855A29_1630"}, {"internal_id": 67440147, "Award ID": "TA317081855A28", "Award Amount": 166356.12, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-03", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "46c9f5fc-0124-8f41-debf-f89950f1ab76-C", "generated_internal_id": "ASST_NON_TA317081855A28_1630"}, {"internal_id": 67440148, "Award ID": "TA317071855A27", "Award Amount": 5544131.92, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-13", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "260ed1ea-1ea9-d6d1-bb92-39df0506ff29-C", "generated_internal_id": "ASST_NON_TA317071855A27_1630"}, {"internal_id": 67803083, "Award ID": "TA317061855A26", "Award Amount": 8030967.05, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-31", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8d56c54c-3c4f-9ba5-e713-5968374ddaac-C", "generated_internal_id": "ASST_NON_TA317061855A26_1630"}, {"internal_id": 67440149, "Award ID": "TA317051855A25", "Award Amount": 5514777.67, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-12", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "21d393fd-60ea-cec2-1d82-d7c447633702-C", "generated_internal_id": "ASST_NON_TA317051855A25_1630"}, {"internal_id": 67440150, "Award ID": "TA317041855A24", "Award Amount": 1523183.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-09", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "4d13a910-0420-2522-e502-49372f5c39e6-C", "generated_internal_id": "ASST_NON_TA317041855A24_1630"}, {"internal_id": 67440151, "Award ID": "TA317031855A23", "Award Amount": 652147.57, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-13", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "ME", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "de5f8d9c-db27-6631-fde3-7b4268a955ef-C", "generated_internal_id": "ASST_NON_TA317031855A23_1630"}, {"internal_id": 67440152, "Award ID": "TA317021855A22", "Award Amount": 598763.31, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-09", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "LA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "610cdfe0-3bf4-21f8-d433-352dba7157e7-C", "generated_internal_id": "ASST_NON_TA317021855A22_1630"}, {"internal_id": 67440153, "Award ID": "TA317011855A21", "Award Amount": 2527279.49, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-03", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "9594ad8f-777a-01e4-21cc-02c0438e9a13-C", "generated_internal_id": "ASST_NON_TA317011855A21_1630"}, {"internal_id": 67440154, "Award ID": "TA317001855A20", "Award Amount": 2826410.78, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-12", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f956af53-7594-bbbb-8c21-e83b2595618e-C", "generated_internal_id": "ASST_NON_TA317001855A20_1630"}, {"internal_id": 67440155, "Award ID": "TA316991855A19", "Award Amount": 2459817.53, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-03", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "38945dff-1d01-d124-868e-296e9cd4b40e-C", "generated_internal_id": "ASST_NON_TA316991855A19_1630"}, {"internal_id": 67440156, "Award ID": "TA316981855A18", "Award Amount": 5427473.15, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-03", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "55a913e6-c7a1-e3ab-3504-a525657ec61b-C", "generated_internal_id": "ASST_NON_TA316981855A18_1630"}, {"internal_id": 67440157, "Award ID": "TA316971855A17", "Award Amount": 5540397.6, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-03", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "49c0b4a8-3274-5dbf-bfdc-21abf88201aa-C", "generated_internal_id": "ASST_NON_TA316971855A17_1630"}, {"internal_id": 67440158, "Award ID": "TA316961855A16", "Award Amount": 713440.05, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-06", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "ID", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c5fe910a-7613-4d8e-4231-e321fb6900ba-C", "generated_internal_id": "ASST_NON_TA316961855A16_1630"}, {"internal_id": 67440159, "Award ID": "TA316951855A15", "Award Amount": 312690.38, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-06", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "HI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "b07eb7d7-3b40-4ce5-2970-f82ed238243f-C", "generated_internal_id": "ASST_NON_TA316951855A15_1630"}, {"internal_id": 67440160, "Award ID": "TA316941855A13", "Award Amount": 4299661.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-06", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "GA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c9860cdb-a017-dfc7-57ec-e362225694da-C", "generated_internal_id": "ASST_NON_TA316941855A13_1630"}, {"internal_id": 67440161, "Award ID": "TA316931855A12", "Award Amount": 1943359.5, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-03", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "aca7fa8c-c5aa-0d3d-29a6-e143b50b9fa4-C", "generated_internal_id": "ASST_NON_TA316931855A12_1630"}, {"internal_id": 67440162, "Award ID": "TA316921855A10", "Award Amount": 121923.34, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-09", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "DE", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bbcd12b4-1518-9503-9648-0f08b880cc1b-C", "generated_internal_id": "ASST_NON_TA316921855A10_1630"}, {"internal_id": 67440163, "Award ID": "TA316911855A9", "Award Amount": 7255876.87, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-09", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "97c80fbf-3298-005f-f24e-73a8b1fd9edb-C", "generated_internal_id": "ASST_NON_TA316911855A9_1630"}, {"internal_id": 67440164, "Award ID": "TA316901855A8", "Award Amount": 1979649.45, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-09", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7ec1af8f-4c5f-a77c-1a5b-21acb44aa1dc-C", "generated_internal_id": "ASST_NON_TA316901855A8_1630"}, {"internal_id": 67440165, "Award ID": "TA316891855A6", "Award Amount": 9425619.31, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-06", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "083b4034-9a44-cecb-a431-8bc83f5db8de-C", "generated_internal_id": "ASST_NON_TA316891855A6_1630"}, {"internal_id": 67440166, "Award ID": "TA316881855A5", "Award Amount": 2566687.79, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-09", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "fbc091b5-34e1-6333-749e-42255d403853-C", "generated_internal_id": "ASST_NON_TA316881855A5_1630"}, {"internal_id": 67440167, "Award ID": "TA316871855A4", "Award Amount": 854496.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-06", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AZ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "dde13409-0b46-f87d-3806-09fdf3ddf74d-C", "generated_internal_id": "ASST_NON_TA316871855A4_1630"}, {"internal_id": 67440168, "Award ID": "TA316851855A1", "Award Amount": 1257195.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2018-07-13", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "80952735-7086-41e5-7b86-e6901d05b705-C", "generated_internal_id": "ASST_NON_TA316851855A1_1630"}, {"internal_id": 50034558, "Award ID": "TA315081855A38", "Award Amount": 426550.0, "Award Type": null, "Base Obligation Date": "2017-12-28", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "ND", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "00a02d4a-e0eb-059f-d8e6-01ce7c006005-C", "generated_internal_id": "ASST_NON_TA315081855A38_1630"}, {"internal_id": 50034557, "Award ID": "TA309451755A27", "Award Amount": 4991231.75, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-17", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "260ed1ea-1ea9-d6d1-bb92-39df0506ff29-C", "generated_internal_id": "ASST_NON_TA309451755A27_1630"}, {"internal_id": 50034556, "Award ID": "TA309431755A22", "Award Amount": 930761.52, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-13", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "LA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "610cdfe0-3bf4-21f8-d433-352dba7157e7-C", "generated_internal_id": "ASST_NON_TA309431755A22_1630"}, {"internal_id": 50034555, "Award ID": "TA309421755A21", "Award Amount": 4812404.5, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c9b235a4-318b-92b9-ecd8-11114346eeb0-C", "generated_internal_id": "ASST_NON_TA309421755A21_1630"}, {"internal_id": 50034554, "Award ID": "TA305201755A56", "Award Amount": 58600.87, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-13", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "a4ee50e1-b77a-155f-5fe3-cedf30e05e1f-C", "generated_internal_id": "ASST_NON_TA305201755A56_1630"}, {"internal_id": 50034552, "Award ID": "TA305181755A55", "Award Amount": 3683164.63, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7a7c092b-646d-1d43-0318-57b1f0f6b91d-C", "generated_internal_id": "ASST_NON_TA305181755A55_1630"}, {"internal_id": 50034551, "Award ID": "TA305171755A53", "Award Amount": 9144779.14, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d32cbf7c-8ae1-2ea4-a158-a0c25c70233f-C", "generated_internal_id": "ASST_NON_TA305171755A53_1630"}, {"internal_id": 50034550, "Award ID": "TA305161755A50", "Award Amount": 453510.87, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "188ec089-7e55-6993-1b6c-c45633c5c525-C", "generated_internal_id": "ASST_NON_TA305161755A50_1630"}, {"internal_id": 50034548, "Award ID": "TA305141755A49", "Award Amount": 1049150.2, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-12", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "UT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "884e85e0-5b57-c7bb-0320-0269c0f42caa-C", "generated_internal_id": "ASST_NON_TA305141755A49_1630"}, {"internal_id": 50034547, "Award ID": "TA305131755A48", "Award Amount": 7492295.72, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-12", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TX", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3f8e6ab8-83f5-3b05-d70f-d6922a8a565e-C", "generated_internal_id": "ASST_NON_TA305131755A48_1630"}, {"internal_id": 50034546, "Award ID": "TA305121755A47", "Award Amount": 2215760.2, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d15d67ff-9bea-1e97-7a91-c4da003d04dd-C", "generated_internal_id": "ASST_NON_TA305121755A47_1630"}, {"internal_id": 50034545, "Award ID": "TA305111755A46", "Award Amount": 312350.35, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-12", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "SD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "359d1c64-c8d3-a5e4-434d-d7d7db0491f7-C", "generated_internal_id": "ASST_NON_TA305111755A46_1630"}, {"internal_id": 50034544, "Award ID": "TA305101755A45", "Award Amount": 3958898.19, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "SC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7c0ab944-f413-12ab-2f1d-8c8c0b402d24-C", "generated_internal_id": "ASST_NON_TA305101755A45_1630"}, {"internal_id": 50034542, "Award ID": "TA305081755A72", "Award Amount": 301277.68, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-17", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8e5e253b-7d1e-bd25-2657-ed39b259a96f-C", "generated_internal_id": "ASST_NON_TA305081755A72_1630"}, {"internal_id": 50034541, "Award ID": "TA305071755A42", "Award Amount": 29571228.01, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-13", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "67111aba-ca04-649d-f45a-abf9aa28596f-C", "generated_internal_id": "ASST_NON_TA305071755A42_1630"}, {"internal_id": 50034539, "Award ID": "TA305051755A40", "Award Amount": 1763198.04, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-13", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OK", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ebe1d86a-aacd-3caf-cf00-6b8e6449590a-C", "generated_internal_id": "ASST_NON_TA305051755A40_1630"}, {"internal_id": 50034537, "Award ID": "TA305031755A36", "Award Amount": 6549090.64, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d2a390c1-d7aa-00da-1424-3e1044c081be-C", "generated_internal_id": "ASST_NON_TA305031755A36_1630"}, {"internal_id": 50034536, "Award ID": "TA305011755A35", "Award Amount": 1912354.06, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-12", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NM", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "468b6b30-c12b-6ee1-ab24-76a78077e304-C", "generated_internal_id": "ASST_NON_TA305011755A35_1630"}, {"internal_id": 50034535, "Award ID": "TA305001755A34", "Award Amount": 4086758.51, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NJ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bbaea497-1a7f-161c-51d7-d8f3c2deccbc-C", "generated_internal_id": "ASST_NON_TA305001755A34_1630"}, {"internal_id": 50034533, "Award ID": "TA304981755A31", "Award Amount": 607584.6, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NE", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "53560a59-1ae6-832d-6db5-3082a56389d5-C", "generated_internal_id": "ASST_NON_TA304981755A31_1630"}, {"internal_id": 50034532, "Award ID": "TA304961755A37", "Award Amount": 2982349.64, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "fa2f5127-5692-2c99-8d92-577968944beb-C", "generated_internal_id": "ASST_NON_TA304961755A37_1630"}, {"internal_id": 50034531, "Award ID": "TA304951755A30", "Award Amount": 502339.52, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-13", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "417d25ce-8d31-fb9d-8657-44dc385f39ad-C", "generated_internal_id": "ASST_NON_TA304951755A30_1630"}, {"internal_id": 50034530, "Award ID": "TA304941755A28", "Award Amount": 317187.06, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "46c9f5fc-0124-8f41-debf-f89950f1ab76-C", "generated_internal_id": "ASST_NON_TA304941755A28_1630"}, {"internal_id": 50034529, "Award ID": "TA304931755A29", "Award Amount": 5461622.87, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "834c7a17-8afe-ef5c-f974-d4c78b3792cd-C", "generated_internal_id": "ASST_NON_TA304931755A29_1630"}, {"internal_id": 50034528, "Award ID": "TA304921755A26", "Award Amount": 9200559.63, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8d56c54c-3c4f-9ba5-e713-5968374ddaac-C", "generated_internal_id": "ASST_NON_TA304921755A26_1630"}, {"internal_id": 50034527, "Award ID": "TA304911755A23", "Award Amount": 989290.46, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "ME", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "de5f8d9c-db27-6631-fde3-7b4268a955ef-C", "generated_internal_id": "ASST_NON_TA304911755A23_1630"}, {"internal_id": 50034525, "Award ID": "TA304891755A25", "Award Amount": 5848314.41, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "21d393fd-60ea-cec2-1d82-d7c447633702-C", "generated_internal_id": "ASST_NON_TA304891755A25_1630"}, {"internal_id": 50034524, "Award ID": "TA304881755A20", "Award Amount": 2199543.41, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f956af53-7594-bbbb-8c21-e83b2595618e-C", "generated_internal_id": "ASST_NON_TA304881755A20_1630"}, {"internal_id": 50034523, "Award ID": "TA304871755A18", "Award Amount": 7907190.48, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "55a913e6-c7a1-e3ab-3504-a525657ec61b-C", "generated_internal_id": "ASST_NON_TA304871755A18_1630"}, {"internal_id": 50034522, "Award ID": "TA304861755A17", "Award Amount": 6621616.25, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "49c0b4a8-3274-5dbf-bfdc-21abf88201aa-C", "generated_internal_id": "ASST_NON_TA304861755A17_1630"}, {"internal_id": 50034521, "Award ID": "TA304851755A16", "Award Amount": 1400174.01, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "ID", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c5fe910a-7613-4d8e-4231-e321fb6900ba-C", "generated_internal_id": "ASST_NON_TA304851755A16_1630"}, {"internal_id": 50034520, "Award ID": "TA304841755A19", "Award Amount": 2766645.31, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "38945dff-1d01-d124-868e-296e9cd4b40e-C", "generated_internal_id": "ASST_NON_TA304841755A19_1630"}, {"internal_id": 50034519, "Award ID": "TA304831755A15", "Award Amount": 427541.85, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "HI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "b07eb7d7-3b40-4ce5-2970-f82ed238243f-C", "generated_internal_id": "ASST_NON_TA304831755A15_1630"}, {"internal_id": 50034517, "Award ID": "TA304811755A12", "Award Amount": 2602720.29, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "aca7fa8c-c5aa-0d3d-29a6-e143b50b9fa4-C", "generated_internal_id": "ASST_NON_TA304811755A12_1630"}, {"internal_id": 50034516, "Award ID": "TA304801755A10", "Award Amount": 155360.48, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-13", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "DE", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bbcd12b4-1518-9503-9648-0f08b880cc1b-C", "generated_internal_id": "ASST_NON_TA304801755A10_1630"}, {"internal_id": 50034514, "Award ID": "TA304781755A8", "Award Amount": 1842007.83, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-13", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7ec1af8f-4c5f-a77c-1a5b-21acb44aa1dc-C", "generated_internal_id": "ASST_NON_TA304781755A8_1630"}, {"internal_id": 50034513, "Award ID": "TA304771755A6", "Award Amount": 4954786.06, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "083b4034-9a44-cecb-a431-8bc83f5db8de-C", "generated_internal_id": "ASST_NON_TA304771755A6_1630"}, {"internal_id": 50034512, "Award ID": "TA304761755A4", "Award Amount": 1056783.13, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AZ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "dde13409-0b46-f87d-3806-09fdf3ddf74d-C", "generated_internal_id": "ASST_NON_TA304761755A4_1630"}, {"internal_id": 50034511, "Award ID": "TA304751755A5", "Award Amount": 3388119.4, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-13", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "fbc091b5-34e1-6333-749e-42255d403853-C", "generated_internal_id": "ASST_NON_TA304751755A5_1630"}, {"internal_id": 50034510, "Award ID": "TA304731755A1", "Award Amount": 774534.42, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2017-07-13", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "80952735-7086-41e5-7b86-e6901d05b705-C", "generated_internal_id": "ASST_NON_TA304731755A1_1630"}, {"internal_id": 50034507, "Award ID": "TA280871655A56", "Award Amount": 46558.3, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "a4ee50e1-b77a-155f-5fe3-cedf30e05e1f-C", "generated_internal_id": "ASST_NON_TA280871655A56_1630"}, {"internal_id": 50034506, "Award ID": "TA280861655A54", "Award Amount": 2671411.01, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WV", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "846a8e3f-aa4e-18cf-c266-755ef5d9cd3b-C", "generated_internal_id": "ASST_NON_TA280861655A54_1630"}, {"internal_id": 50034505, "Award ID": "TA280851655A55", "Award Amount": 4181311.54, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7a7c092b-646d-1d43-0318-57b1f0f6b91d-C", "generated_internal_id": "ASST_NON_TA280851655A55_1630"}, {"internal_id": 50034503, "Award ID": "TA280831655A50", "Award Amount": 522919.8, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "188ec089-7e55-6993-1b6c-c45633c5c525-C", "generated_internal_id": "ASST_NON_TA280831655A50_1630"}, {"internal_id": 50034502, "Award ID": "TA280811655A51", "Award Amount": 2965094.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-17", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "cdf64453-c591-7dc4-091e-bcc8ce4b3bf8-C", "generated_internal_id": "ASST_NON_TA280811655A51_1630"}, {"internal_id": 50034501, "Award ID": "TA280801655A49", "Award Amount": 1980003.95, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-11", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "UT", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "884e85e0-5b57-c7bb-0320-0269c0f42caa-C", "generated_internal_id": "ASST_NON_TA280801655A49_1630"}, {"internal_id": 50034500, "Award ID": "TA280791655A48", "Award Amount": 10357046.87, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TX", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3f8e6ab8-83f5-3b05-d70f-d6922a8a565e-C", "generated_internal_id": "ASST_NON_TA280791655A48_1630"}, {"internal_id": 50034499, "Award ID": "TA280781655A47", "Award Amount": 2166950.25, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d15d67ff-9bea-1e97-7a91-c4da003d04dd-C", "generated_internal_id": "ASST_NON_TA280781655A47_1630"}, {"internal_id": 50034498, "Award ID": "TA280771655A46", "Award Amount": 495363.05, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "SD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "359d1c64-c8d3-a5e4-434d-d7d7db0491f7-C", "generated_internal_id": "ASST_NON_TA280771655A46_1630"}, {"internal_id": 50034497, "Award ID": "TA280761655A45", "Award Amount": 4207581.5, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "SC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7c0ab944-f413-12ab-2f1d-8c8c0b402d24-C", "generated_internal_id": "ASST_NON_TA280761655A45_1630"}, {"internal_id": 50034496, "Award ID": "TA280751655A44", "Award Amount": 1335753.93, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "RI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e9f0421d-cc22-21bc-7918-abb8af4d0be3-C", "generated_internal_id": "ASST_NON_TA280751655A44_1630"}, {"internal_id": 50034495, "Award ID": "TA280741655A72", "Award Amount": 499804.13, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8e5e253b-7d1e-bd25-2657-ed39b259a96f-C", "generated_internal_id": "ASST_NON_TA280741655A72_1630"}, {"internal_id": 50034492, "Award ID": "TA280711655A40", "Award Amount": 3818790.44, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OK", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "ebe1d86a-aacd-3caf-cf00-6b8e6449590a-C", "generated_internal_id": "ASST_NON_TA280711655A40_1630"}, {"internal_id": 50034490, "Award ID": "TA280691655A36", "Award Amount": 7427198.43, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d2a390c1-d7aa-00da-1424-3e1044c081be-C", "generated_internal_id": "ASST_NON_TA280691655A36_1630"}, {"internal_id": 50034489, "Award ID": "TA280681655A32", "Award Amount": 157099.81, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NV", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c079e5d2-db3e-6b13-6c7c-407a8c93521d-C", "generated_internal_id": "ASST_NON_TA280681655A32_1630"}, {"internal_id": 50034488, "Award ID": "TA280671655A35", "Award Amount": 2998555.92, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NM", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "468b6b30-c12b-6ee1-ab24-76a78077e304-C", "generated_internal_id": "ASST_NON_TA280671655A35_1630"}, {"internal_id": 50034487, "Award ID": "TA280661655A34", "Award Amount": 5690669.85, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NJ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bbaea497-1a7f-161c-51d7-d8f3c2deccbc-C", "generated_internal_id": "ASST_NON_TA280661655A34_1630"}, {"internal_id": 50034486, "Award ID": "TA280651655A33", "Award Amount": 710545.02, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "544f5a0a-2ccc-8ec6-6643-9ddd180c37d2-C", "generated_internal_id": "ASST_NON_TA280651655A33_1630"}, {"internal_id": 50034485, "Award ID": "TA280641655A31", "Award Amount": 443019.12, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NE", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "53560a59-1ae6-832d-6db5-3082a56389d5-C", "generated_internal_id": "ASST_NON_TA280641655A31_1630"}, {"internal_id": 50034484, "Award ID": "TA280621655A37", "Award Amount": 4365478.4, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "fa2f5127-5692-2c99-8d92-577968944beb-C", "generated_internal_id": "ASST_NON_TA280621655A37_1630"}, {"internal_id": 50034482, "Award ID": "TA280601655A29", "Award Amount": 6009870.32, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "834c7a17-8afe-ef5c-f974-d4c78b3792cd-C", "generated_internal_id": "ASST_NON_TA280601655A29_1630"}, {"internal_id": 50034481, "Award ID": "TA280591655A28", "Award Amount": 368419.37, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "46c9f5fc-0124-8f41-debf-f89950f1ab76-C", "generated_internal_id": "ASST_NON_TA280591655A28_1630"}, {"internal_id": 50034480, "Award ID": "TA280581655A27", "Award Amount": 5044857.02, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "260ed1ea-1ea9-d6d1-bb92-39df0506ff29-C", "generated_internal_id": "ASST_NON_TA280581655A27_1630"}, {"internal_id": 50034479, "Award ID": "TA280571655A26", "Award Amount": 9467660.61, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8d56c54c-3c4f-9ba5-e713-5968374ddaac-C", "generated_internal_id": "ASST_NON_TA280571655A26_1630"}, {"internal_id": 50034478, "Award ID": "TA280561655A25", "Award Amount": 5807684.03, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-17", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "21d393fd-60ea-cec2-1d82-d7c447633702-C", "generated_internal_id": "ASST_NON_TA280561655A25_1630"}, {"internal_id": 50034477, "Award ID": "TA280551655A24", "Award Amount": 1617873.56, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "4d13a910-0420-2522-e502-49372f5c39e6-C", "generated_internal_id": "ASST_NON_TA280551655A24_1630"}, {"internal_id": 50034476, "Award ID": "TA280541655A23", "Award Amount": 3217336.44, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "ME", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "de5f8d9c-db27-6631-fde3-7b4268a955ef-C", "generated_internal_id": "ASST_NON_TA280541655A23_1630"}, {"internal_id": 50034475, "Award ID": "TA280531655A22", "Award Amount": 549947.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "LA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "610cdfe0-3bf4-21f8-d433-352dba7157e7-C", "generated_internal_id": "ASST_NON_TA280531655A22_1630"}, {"internal_id": 50034474, "Award ID": "TA280521655A21", "Award Amount": 9414833.88, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-18", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c9b235a4-318b-92b9-ecd8-11114346eeb0-C", "generated_internal_id": "ASST_NON_TA280521655A21_1630"}, {"internal_id": 50034473, "Award ID": "TA280511655A20", "Award Amount": 2694919.45, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f956af53-7594-bbbb-8c21-e83b2595618e-C", "generated_internal_id": "ASST_NON_TA280511655A20_1630"}, {"internal_id": 50034472, "Award ID": "TA280501655A19", "Award Amount": 7332175.99, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "38945dff-1d01-d124-868e-296e9cd4b40e-C", "generated_internal_id": "ASST_NON_TA280501655A19_1630"}, {"internal_id": 50034471, "Award ID": "TA280491655A18", "Award Amount": 6132529.21, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "55a913e6-c7a1-e3ab-3504-a525657ec61b-C", "generated_internal_id": "ASST_NON_TA280491655A18_1630"}, {"internal_id": 50034470, "Award ID": "TA280481655A17", "Award Amount": 11753807.39, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "49c0b4a8-3274-5dbf-bfdc-21abf88201aa-C", "generated_internal_id": "ASST_NON_TA280481655A17_1630"}, {"internal_id": 50034469, "Award ID": "TA280471655A16", "Award Amount": 1619025.05, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "ID", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c5fe910a-7613-4d8e-4231-e321fb6900ba-C", "generated_internal_id": "ASST_NON_TA280471655A16_1630"}, {"internal_id": 50034468, "Award ID": "TA280461655A15", "Award Amount": 1677654.26, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-04-28", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "HI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "b07eb7d7-3b40-4ce5-2970-f82ed238243f-C", "generated_internal_id": "ASST_NON_TA280461655A15_1630"}, {"internal_id": 50034466, "Award ID": "TA280441655A12", "Award Amount": 2142480.91, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "aca7fa8c-c5aa-0d3d-29a6-e143b50b9fa4-C", "generated_internal_id": "ASST_NON_TA280441655A12_1630"}, {"internal_id": 50034465, "Award ID": "TA280421655A10", "Award Amount": 318166.57, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "DE", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bbcd12b4-1518-9503-9648-0f08b880cc1b-C", "generated_internal_id": "ASST_NON_TA280421655A10_1630"}, {"internal_id": 50034463, "Award ID": "TA280401655A8", "Award Amount": 1690614.43, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CO", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7ec1af8f-4c5f-a77c-1a5b-21acb44aa1dc-C", "generated_internal_id": "ASST_NON_TA280401655A8_1630"}, {"internal_id": 50034462, "Award ID": "TA280391655A6", "Award Amount": 6362623.81, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "083b4034-9a44-cecb-a431-8bc83f5db8de-C", "generated_internal_id": "ASST_NON_TA280391655A6_1630"}, {"internal_id": 50034461, "Award ID": "TA280381655A5", "Award Amount": 4623836.32, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "fbc091b5-34e1-6333-749e-42255d403853-C", "generated_internal_id": "ASST_NON_TA280381655A5_1630"}, {"internal_id": 50034460, "Award ID": "TA280371655A4", "Award Amount": 917055.18, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AZ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "dde13409-0b46-f87d-3806-09fdf3ddf74d-C", "generated_internal_id": "ASST_NON_TA280371655A4_1630"}, {"internal_id": 50034459, "Award ID": "TA280351655A1", "Award Amount": 628925.0, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2016-05-05", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "80952735-7086-41e5-7b86-e6901d05b705-C", "generated_internal_id": "ASST_NON_TA280351655A1_1630"}, {"internal_id": 50034458, "Award ID": "TA267601555A16", "Award Amount": 1531877.61, "Award Type": null, "Base Obligation Date": "2015-05-22", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "ID", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c5fe910a-7613-4d8e-4231-e321fb6900ba-C", "generated_internal_id": "ASST_NON_TA267601555A16_1630"}, {"internal_id": 50034457, "Award ID": "TA267581555A55", "Award Amount": 4716201.67, "Award Type": null, "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7a7c092b-646d-1d43-0318-57b1f0f6b91d-C", "generated_internal_id": "ASST_NON_TA267581555A55_1630"}, {"internal_id": 50034456, "Award ID": "TA267571555A54", "Award Amount": 2287171.77, "Award Type": null, "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WV", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "846a8e3f-aa4e-18cf-c266-755ef5d9cd3b-C", "generated_internal_id": "ASST_NON_TA267571555A54_1630"}, {"internal_id": 50034454, "Award ID": "TA267551555A51", "Award Amount": 1652102.0, "Award Type": null, "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "VA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "cdf64453-c591-7dc4-091e-bcc8ce4b3bf8-C", "generated_internal_id": "ASST_NON_TA267551555A51_1630"}, {"internal_id": 50034452, "Award ID": "TA267531555A48", "Award Amount": 16065890.86, "Award Type": null, "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TX", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "3f8e6ab8-83f5-3b05-d70f-d6922a8a565e-C", "generated_internal_id": "ASST_NON_TA267531555A48_1630"}, {"internal_id": 50034451, "Award ID": "TA267521555A47", "Award Amount": 2262651.54, "Award Type": null, "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "TN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d15d67ff-9bea-1e97-7a91-c4da003d04dd-C", "generated_internal_id": "ASST_NON_TA267521555A47_1630"}, {"internal_id": 50034449, "Award ID": "TA267501555A45", "Award Amount": 5231215.78, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2015-06-01", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "SC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "7c0ab944-f413-12ab-2f1d-8c8c0b402d24-C", "generated_internal_id": "ASST_NON_TA267501555A45_1630"}, {"internal_id": 50034448, "Award ID": "TA267491555A44", "Award Amount": 612528.85, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "RI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e9f0421d-cc22-21bc-7918-abb8af4d0be3-C", "generated_internal_id": "ASST_NON_TA267491555A44_1630"}, {"internal_id": 50034447, "Award ID": "TA267481555A72", "Award Amount": 352417.98, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "8e5e253b-7d1e-bd25-2657-ed39b259a96f-C", "generated_internal_id": "ASST_NON_TA267481555A72_1630"}, {"internal_id": 50034443, "Award ID": "TA267441555A39", "Award Amount": 9736247.84, "Award Type": null, "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "OH", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "5328a709-be88-a95a-5c48-ac49aa83adc7-C", "generated_internal_id": "ASST_NON_TA267441555A39_1630"}, {"internal_id": 50034442, "Award ID": "TA267421555A37", "Award Amount": 6631850.76, "Award Type": null, "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "fa2f5127-5692-2c99-8d92-577968944beb-C", "generated_internal_id": "ASST_NON_TA267421555A37_1630"}, {"internal_id": 50034441, "Award ID": "TA267411555A36", "Award Amount": 6964408.63, "Award Type": null, "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "d2a390c1-d7aa-00da-1424-3e1044c081be-C", "generated_internal_id": "ASST_NON_TA267411555A36_1630"}, {"internal_id": 50034439, "Award ID": "TA267391555A34", "Award Amount": 4580467.95, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NJ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bbaea497-1a7f-161c-51d7-d8f3c2deccbc-C", "generated_internal_id": "ASST_NON_TA267391555A34_1630"}, {"internal_id": 50034437, "Award ID": "TA267361555A31", "Award Amount": 314476.66, "Award Type": null, "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NE", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "53560a59-1ae6-832d-6db5-3082a56389d5-C", "generated_internal_id": "ASST_NON_TA267361555A31_1630"}, {"internal_id": 50034435, "Award ID": "TA267331555A28", "Award Amount": 629440.79, "Award Type": null, "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "46c9f5fc-0124-8f41-debf-f89950f1ab76-C", "generated_internal_id": "ASST_NON_TA267331555A28_1630"}, {"internal_id": 50034434, "Award ID": "TA267321555A27", "Award Amount": 6523111.13, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "69340269-e3d5-d870-39fe-50cdc50b8fe2-C", "generated_internal_id": "ASST_NON_TA267321555A27_1630"}, {"internal_id": 50034433, "Award ID": "TA267311555A26", "Award Amount": 10453495.4, "Award Type": null, "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MI", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "6303c596-4c97-b8d6-45a4-b9a609623b4b-C", "generated_internal_id": "ASST_NON_TA267311555A26_1630"}, {"internal_id": 50034431, "Award ID": "TA267291555A24", "Award Amount": 1767143.22, "Award Type": null, "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MD", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "4d13a910-0420-2522-e502-49372f5c39e6-C", "generated_internal_id": "ASST_NON_TA267291555A24_1630"}, {"internal_id": 50034429, "Award ID": "TA267271555A22", "Award Amount": 747695.01, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "LA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "610cdfe0-3bf4-21f8-d433-352dba7157e7-C", "generated_internal_id": "ASST_NON_TA267271555A22_1630"}, {"internal_id": 50034428, "Award ID": "TA267261555A21", "Award Amount": 4196459.21, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "c9b235a4-318b-92b9-ecd8-11114346eeb0-C", "generated_internal_id": "ASST_NON_TA267261555A21_1630"}, {"internal_id": 50034427, "Award ID": "TA267251555A20", "Award Amount": 1858586.15, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KS", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "f956af53-7594-bbbb-8c21-e83b2595618e-C", "generated_internal_id": "ASST_NON_TA267251555A20_1630"}, {"internal_id": 50034425, "Award ID": "TA267231555A18", "Award Amount": 3032916.11, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IN", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "55a913e6-c7a1-e3ab-3504-a525657ec61b-C", "generated_internal_id": "ASST_NON_TA267231555A18_1630"}, {"internal_id": 50034424, "Award ID": "TA267221555A17", "Award Amount": 5673069.32, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "IL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "49c0b4a8-3274-5dbf-bfdc-21abf88201aa-C", "generated_internal_id": "ASST_NON_TA267221555A17_1630"}, {"internal_id": 50034422, "Award ID": "TA267191555A12", "Award Amount": 2079502.04, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2015-05-19", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "FL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "aca7fa8c-c5aa-0d3d-29a6-e143b50b9fa4-C", "generated_internal_id": "ASST_NON_TA267191555A12_1630"}, {"internal_id": 50034421, "Award ID": "TA267181555A11", "Award Amount": 90630.67, "Award Type": null, "Base Obligation Date": "2015-04-24", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "DC", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "66f1868e-a3ad-5162-6995-ceda714eddd9-C", "generated_internal_id": "ASST_NON_TA267181555A11_1630"}, {"internal_id": 50034418, "Award ID": "TA267151555A6", "Award Amount": 7307429.0, "Award Type": null, "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "CA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "083b4034-9a44-cecb-a431-8bc83f5db8de-C", "generated_internal_id": "ASST_NON_TA267151555A6_1630"}, {"internal_id": 50034417, "Award ID": "TA267141555A5", "Award Amount": 8344426.5, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AR", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "fbc091b5-34e1-6333-749e-42255d403853-C", "generated_internal_id": "ASST_NON_TA267141555A5_1630"}, {"internal_id": 50034416, "Award ID": "TA267131555A4", "Award Amount": 834596.03, "Award Type": null, "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AZ", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "dde13409-0b46-f87d-3806-09fdf3ddf74d-C", "generated_internal_id": "ASST_NON_TA267131555A4_1630"}, {"internal_id": 50034415, "Award ID": "TA267111555A1", "Award Amount": 1558103.0, "Award Type": null, "Base Obligation Date": "2015-03-20", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AL", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "80952735-7086-41e5-7b86-e6901d05b705-C", "generated_internal_id": "ASST_NON_TA267111555A1_1630"}, {"internal_id": 50034413, "Award ID": "TA267021555A10", "Award Amount": 320150.86, "Award Type": "FORMULA GRANT (A)", "Base Obligation Date": "2015-01-15", "CFDA Number": "17.245", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "DE", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "bbcd12b4-1518-9503-9648-0f08b880cc1b-C", "generated_internal_id": "ASST_NON_TA267021555A10_1630"}, {"internal_id": 48844513, "Award ID": "HC305291760A42", "Award Amount": 36760.16, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-06-09", "CFDA Number": "17.276", "Description": "HEALTH COVERAGE TAX CREDIT (HCTC)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "PA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "67111aba-ca04-649d-f45a-abf9aa28596f-C", "generated_internal_id": "ASST_NON_HC305291760A42_1630"}, {"internal_id": 48844512, "Award ID": "HC303081760A21", "Award Amount": 20716.35, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-03-09", "CFDA Number": "17.276", "Description": "HEALTH COVERAGE TAX CREDIT (HCTC)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "KY", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "e9fe6408-77ac-f45c-43b8-22585b915e02-C", "generated_internal_id": "ASST_NON_HC303081760A21_1630"}, {"internal_id": 48844510, "Award ID": "HC303051760A25", "Award Amount": 21747.52, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-03-09", "CFDA Number": "17.276", "Description": "TRADE ADJUSTMENT ASSISTANCE", "Place of Performance Country Code": "USA", "Place of Performance State Code": "MA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "21d393fd-60ea-cec2-1d82-d7c447633702-C", "generated_internal_id": "ASST_NON_HC303051760A25_1630"}, {"internal_id": 48844508, "Award ID": "HC303031760A2", "Award Amount": 101644.77, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2017-03-07", "CFDA Number": "17.276", "Description": "HEALTH COVERAGE TAX CREDIT (HCTC)", "Place of Performance Country Code": "USA", "Place of Performance State Code": "AK", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "dd9c0bbb-48d7-8e4e-2542-8f94d7cb2289-C", "generated_internal_id": "ASST_NON_HC303031760A2_1630"}, {"internal_id": 103564080, "Award ID": "AD352272060A35", "Award Amount": 3295882.09, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-07-14", "CFDA Number": "17.245", "Description": "SENIOR COMMUNITY SERVICE EMPLOYMENT PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "NM", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "a4fe3ce8-ccb5-a679-312c-5c1f8d98c639-C", "generated_internal_id": "ASST_NON_AD352272060A35_1630"}, {"internal_id": 103564079, "Award ID": "AD352262060A53", "Award Amount": 5461721.47, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-07-16", "CFDA Number": "17.245", "Description": "SENIOR COMMUNITY SERVICE EMPLOYMENT PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "WA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "a9a70b56-5b2b-a938-a510-a04e87ee08fa-C", "generated_internal_id": "ASST_NON_AD352262060A53_1630"}, {"internal_id": 103564075, "Award ID": "AD352252060A22", "Award Amount": 2076418.98, "Award Type": "PROJECT GRANT (B)", "Base Obligation Date": "2020-07-14", "CFDA Number": "17.245", "Description": "SENIOR COMMUNITY SERVICE EMPLOYMENT PROGRAM", "Place of Performance Country Code": "USA", "Place of Performance State Code": "LA", "COVID-19 Obligations": null, "Infrastructure Obligations": null, "recipient_id": "6b858e6c-915c-fd9f-6edb-33f90236cf8f-R", "generated_internal_id": "ASST_NON_AD352252060A22_1630"}]